Acadia Healthcare Stock: 6 Straight Green Days, Up 31%
Acadia Healthcare (ACHC) stock has risen for 6 consecutive trading days, gaining 31.0% over that stretch. That added about $834 million to the company’s market value, which now stands at about $3.5 billion. The stock closed at $38.80 on Wednesday, November 11, its highest close of the past year.
The Streak Next To The S&P 500
Returns for ACHC and the S&P 500 over the streak and the periods around it, all ending Wednesday, November 11 and including dividends:
| Return Period | ACHC | S&P 500 |
|---|---|---|
| 1 Day | 0.4% | 1.3% |
| 6 Days (Current Streak) | 31.0% | 0.7% |
| 1 Month (21 Trading Days) | 28.3% | -2.3% |
| 3 Months (63 Trading Days) | 28.3% | -2.0% |
| Year To Date | 173.4% | 12.4% |
| 1 Year (252 Trading Days) | 113.5% | 12.8% |
Is This Move About Acadia Healthcare Or The Market?
Over the same 6 trading days, the S&P 500 returned +0.7% including dividends, so the run is mostly Acadia Healthcare’s own story rather than the market’s. Over the past three months the stock is up 28.3%, a window that includes the streak; over the other 57 sessions of that window it was down 2.1%.
Is The Business Keeping Up With The Stock?
On the fundamentals, revenue grew 4.5% over the last twelve months, against a median of 7.9% for S&P 500 Health Care stocks; and its operating margin is 9.8%, versus a median of 17.4%. Acadia Healthcare does not have positive trailing earnings, so there is no meaningful price-to-earnings multiple to compare. The read is mixed.
A climb like this is worth respecting, and worth testing. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.
One Hot Stock Is A Story. Thirty Sound Ones Are A Strategy
A streak like this earns a place on your watchlist, and it also earns a question: how much of your outcome do you want depending on one company keeping this up?
The Trefis High Quality (HQ) Portfolio answers it with breadth: roughly 30 businesses picked for consistent cash generation, strong margins, and balance-sheet strength, sized and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Follow the story; invest in the strategy.